BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Tenax Therapeutics Inc.

Headquarters: Chapel Hill, NC, United States
Year Founded: 1990
Status: Public
Industry Sector: HealthTechnology
CEO: Christopher T. Giordano
Number Of Employees: 6
Enterprise Value: $-319,146
PE Ratio: -1.06
Exchange/Ticker 1: NASDAQ:TENX
Exchange/Ticker 2: N/A
Latest Market Cap: $23,916,000